PT - JOURNAL ARTICLE AU - Medina, Angélica AU - Sussman, Jacob AU - Sosa, Natalia AU - Valdez, Melissa AU - Andrews, Jason R. AU - Croda, Julio AU - Sanabria, Gladys Estigarribia AU - Sequera, Guillermo AU - Aguirre, Sarita AU - Walter, Katharine S. TI - The concentration of tuberculosis within Paraguay’s incarcerated and Indigenous populations, 2018-2022 AID - 10.1101/2024.05.31.24308287 DP - 2024 Jan 01 TA - medRxiv PG - 2024.05.31.24308287 4099 - http://medrxiv.org/content/early/2024/06/01/2024.05.31.24308287.short 4100 - http://medrxiv.org/content/early/2024/06/01/2024.05.31.24308287.full AB - While incidence of tuberculosis (TB) has decreased globally, in Paraguay, considered a medium-incidence country by the WHO, TB incidence has increased slightly from 42 per 100,000 in 2010 to 46 per 100,000 in 2022. We conducted a retrospective study of TB cases notified to the Paraguay National Program for Tuberculosis Control (NPTC) from 2018 to 2022 and quantified trends in specific populations identified as vulnerable. Of the 13,725 TB cases notified in Paraguay from 2018 to 2022, 2,331 (17%) occurred among incarcerated individuals and 1,743 (12.7%) occurred among self-identified Indigenous individuals. In 2022, the relative risk of TB was 87 and 6.4 among the incarcerated and Indigenous populations, compared with the non-incarcerated and non-Indigenous populations respectively. We found significant heterogeneity in TB incidence across Paraguay’s 17 departments. Our findings highlight the urgency of expanding access to TB diagnosis, treatment, and prevention in populations at heightened risk of TB in Paraguay.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by K01AI173385 (NIH, NIAID), University of Utah Undergraduate Research Opportunity ProgramAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of the University of Utah waived ethical approval for this work. The ethics committee of the Instituto de Medicina Tropical, Asunción, Paraguay gave ethical approval for this word.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.